Clinical Trial Update: AZD0530 (NSC 735464) in Treating Patients With Previously Treated Metastatic Colon Cancer or Rectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial of AZD0530 in previously treated metastatic colon or rectal cancer was terminated with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adenocarcinoma of the Colon
• Adenocarcinoma of the Rectum
• Colon Cancer
• Rectal Cancer

Drugs mentioned

• AZD0530 (saracatinib)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum | Phase 2 | Status: TERMINATED | Results posted: 2014-02-06